Reata Pharmaceuticals, Inc. to Report Second Quarter 2019 Financials and to Provide an Update on Development Programs on Augu...
August 01 2019 - 6:45AM
Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage
biopharmaceutical company, today announced that it will report
financial results and provide an update on recent progress on its
development programs on Thursday, August 8, 2019, at 8:00 a.m. ET
before the market opens.
The conference call will be accessible by
dialing (844) 348-3946 (toll-free domestic) or (213) 358-0892
(international) using the access code: 7587139. The webcast link is
https://edge.media-server.com/mmc/p/h8xmbyuj.
Second quarter financial results to be discussed
during the call will be included in an earnings press release that
will be available on the company’s website shortly before the call
at http://reatapharma.com/investors/ and will be available for 12
months after the call. The audio recording and webcast will be
accessible for at least 90 days after the event at
http://reatapharma.com/investors/.
About Reata Pharmaceuticals,
Inc.
Reata is a clinical-stage biopharmaceutical
company that develops novel therapeutics for patients with serious
or life-threatening diseases by targeting molecular pathways
involved in the regulation of cellular metabolism and inflammation.
Reata’s two most advanced clinical candidates, bardoxolone methyl
(bardoxolone) and omaveloxolone, target the important transcription
factor Nrf2 that promotes restoration of mitochondrial function,
reduction of oxidative stress, and inhibition of pro-inflammatory
signaling. Bardoxolone and omaveloxolone are
investigational drugs, and their safety and efficacy have not been
established by any agency.
Contact:Reata Pharmaceuticals,
Inc.(972) 865-2219http://reatapharma.com
Investors:Vinny JindalVice
President, Strategy(469)
374-8721ir@reatapharma.comhttp://reatapharma.com/contact-us/
Media:Matt Middleman,
M.D.LifeSci Public Relations(646)
627-8384matt.middleman@lifescipublicrelations.com
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Apr 2023 to Apr 2024